Navigation Links
PAREXEL International to Present at William Blair Emerging Growth Stock Conference
Date:9/30/2009

BOSTON, Sept. 30 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the William Blair Emerging Growth Stock Conference in New York, NY. James Winschel, Senior Vice President and Chief Financial Officer, will be making a formal presentation on PAREXEL at 3:30 p.m. EDT on Tuesday, October 6, 2009.

A live webcast of this presentation will be available under the "Upcoming Events" section on PAREXEL's "Investors" homepage at www.PAREXEL.com. A replay of the presentation will be available until November 5, 2009.

About the Company

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 70 locations throughout 52 countries around the world, and has over 9,275 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
2. PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru
3. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
4. PAREXEL Expands Global Clinical Pharmacology Capabilities
5. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
6. OPAXIO(TM) Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annual Meeting
7. New Micro-Bland Embolization Technique with Embozene(TM) Microspheres to Be Presented at the International Medical Conference in Lisbon, Portugal
8. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
9. Cellular Dynamics International and VivoMedica Launch the CARDIOTOX Consortium to Validate a Human Cardiac Model for Preclinical Cardiotoxicity Testing
10. MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
11. MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  The strongest ... market is the increasing elderly population, according to ... recent report from the healthcare market research publisher, ... coupled with other risk factors such as obesity ... worldwide. Demand for innovative product designs and the ...
(Date:3/4/2015)... Mass., March 4, 2015 GSI Group Inc. ... "GSI"),  a global leader and supplier of precision photonics ... equipment and advanced industrial technology markets, today reported financial ... Unless otherwise noted, all financial results in this press ... Fourth QuarterDuring the fourth quarter of 2014, GSI ...
(Date:3/4/2015)... March 4, 2015 Amgen (NASDAQ: ... declared a $0.79 per share dividend for the second ... June 5, 2015, to all stockholders of record as ... About Amgen Amgen is committed to ... serious illnesses by discovering, developing, manufacturing and delivering innovative ...
Breaking Medicine Technology:Kalorama: Growing Elderly Population Drives Orthopedic Device Market 2Kalorama: Growing Elderly Population Drives Orthopedic Device Market 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 28GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 29GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 30GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 31GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 32GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 33Amgen Announces 2015 Second Quarter Dividend 2
(Date:3/5/2015)... 05, 2015 Aureus Medical Group (web: ... tenens and direct hire physician jobs, has announced that ... Academy of Family Physicians 67th Annual Meeting & Scientific ... Vista, Nebraska. , The Annual Meeting & Scientific ... networking opportunities, and an exhibition of products and services. ...
(Date:3/5/2015)... New fiber fix heat wrap, a fiber glass adhesive launched ... kind product, manufactured to withstand the highest of temperatures. This ... in the market by customers who look to mold together ... cannot be done with the usual adhesives. , A spokesperson ... our new product Fiber Fix Heat Warp and already see ...
(Date:3/5/2015)... Afterglow®, a revolutionary vibrator reimagined ... just been rated #1 in Buzzfeed's "16 Sex ... by urogynecologist Dr. Ralph Zipper, Afterglow® ... by themselves and with their partners. , Afterglow® ... enhance a women's sensual experience with science discovered ...
(Date:3/5/2015)... NV (PRWEB) March 05, 2015 In ... products to help patients, Soho Flordis International (SFI) has ... , SFI is a global natural medicine company committed ... of evidence of quality, safety, and effectiveness. For these ... Varro E. Tyler Commercial Investment in Phytomedicinal Research Award. ...
(Date:3/5/2015)... 05, 2015 Building on its commitment ... relevant information, The Academy of Oncology Nurse & Patient ... the patient voice ™ (CONQUER ™). , ... of people and their loved ones each year,” says ... “More than ever, there is a need in the ...
Breaking Medicine News(10 mins):Health News:Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the Nebraska Academy of Family Physicians Annual Meeting & Scientific Assembly 2Health News:TheHardwareCity.com Launches New Fiber Fix Heat Wrap For High Temperature Applications 2Health News:Doctor’s Afterglow® Vibrator Enhances Women’s Arousal Using Light Waves, Ranks #1 In "Sex Toys That Are Better Than A Boyfriend" 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 2Health News:SFI Receives Prestigious ABC’s Tyler Award Given For Global Research Effort 3Health News:The Academy of Oncology Nurse & Patient Navigators Launches CONQUER: the patient voice™ to Help Meet the Informational Needs of Patients with Cancer 2
... York, NY, October 23, 2009A new Commonwealth Fund report ... current bills passed by the five committees of jurisdiction ... Education, Labor, and Pensions (HELP) Committees in the Senate ... Education and Labor, and Energy and Commerce committees. ...
... The University of Alabama at Birmingham (UAB) is ... repository to enable researchers to identify predictors of effectiveness ... the most common type of inflammatory arthritis. Many effective ... side effects, and there is no way to predict ...
... as well as seven-day regimen, researchers find , FRIDAY, Oct. ... be as effective as a seven-day course in reducing pain ... found. , The study appears in the October issue of ... . , Pain after a tonsillectomy can make children reluctant ...
... cycles could have health consequences, study finds , FRIDAY, ... at night may cause depression, suggests a new study. , ... lighted room 24 hours a day had more depressive symptoms ... also found that mice that lived in a constantly lit ...
... Each year 3-5 million people have severe cases and ... year, the novel 2009 H1N1 (nH1N1) influenza, previously called ... H1N1 is a viral infection of the respiratory tract, ... donors, as well as for the healthcare workers involved ...
... Ga. An extract in red grape skin may be ... Georgia researchers say. The extract, resveratrol, a natural chemical ... has been found to induce production of fetal hemoglobin, which ... painful vascular episodes associated with the disease. Most ...
Cached Medicine News:Health News:Analysis of Congressional health reform bills highlights similarities, differences, costs 2Health News:UAB creates national network to advance personalized medicine in rheumatoid arthritis 2Health News:After Tonsillectomy, Short-Term Antibiotics Effective: Study 2Health News:Constant Light Linked to Symptoms of Depression 2Health News:Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation 2Health News:Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation 3Health News:Red grape skin extract could be new treatment for sickle cell disease patients 2
Near PT test card/Tumbling E, tumbling hands 5 1/2" X 8"....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... The PowerLab/4SP is a high-performance data acquisition ... research applications including human and animal physiology, ... engineering. The unit is capable of recording ... (up to 200 000 samples per second ...
Medicine Products: